RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer

RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer

Radiation therapy is a common and acceptable approach for lung cancer. Although the benefit of ionizing radiation (IR) is well-established, cancer cells can still survive via pro-survival and metastasis signaling pathways. Ras related C3 botulinum toxin substrate1 (RAC1), a member of Rho family GTPa...

Full description

Bibliographic Details
Main Authors: Shiming Tan, Pin Yi, Heran Wang, Longzheng Xia, Yaqian Han, Hui Wang, Biao Zeng, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Linda Oyang, Jiaxin Liang, Jinguan Lin, Min Su, Yingrui Shi, Qianjin Liao, Yujuan Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
RAC1
lung cancer
radioresistance
epithelial-to-mesenchymal transition
metastasis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00649/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00649/full

Similar Items